The Amsterdam-based firm said it was a defendant "in several class-action lawsuits and individual personal injury claims" in the United States due to safety issues with the device. "This quarter, Philips Respironics recorded a 575 million euro ($635 million) provision in connection with the anticipated resolution of the economic loss class action," Philips said as it announced its first quarter results.
